Imprivata Stock Price, News & Analysis (NYSE:IMPR)

$19.26 0.01 (0.05 %)
(As of 12/13/2017 04:00 PM ET)
Previous Close$19.25
Today's Range$19.24 - $19.27
52-Week Range$9.00 - $20.32
Volume199,900 shs
Average Volume258,396 shs
Market Capitalization$492.60 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Imprivata (NYSE:IMPR)

Imprivata logoImprivata, Inc. (Imprivata) is a United States-based healthcare information technology security company. The Company enables healthcare organizations to access, communicate and transact patient information securely. The Company offers Imprivata OneSign, Imprivata Cortext, Imprivata Confirm ID and Imprivata PatientSecure. Imprivata OneSign provides single sign-on, authentication management and virtual desktop roaming, enabling No Click Access to clinical applications and patient information, anytime, anywhere and from any device. Imprivata Cortext enables clinicians to collaborate across care teams and organizations. Imprivata Confirm ID is an identity and two-factor authentication platform for remote access, electronic prescriptions for controlled substances (EPCS), medical device access and other clinical authentication workflows. Imprivata PatientSecure is a patient identification solution that uses palm vein recognition biometrics to identify patients at any point of entry to care.

Receive IMPR News and Ratings via Email

Sign-up to receive the latest news and ratings for IMPR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Enterprise Software
Sub-IndustryN/A
SectorTechnology
SymbolNYSE:IMPR
CUSIPN/A
Phone+1-781-6742700

Debt

Debt-to-Equity RatioN/A
Current Ratio1.31%
Quick Ratio1.31%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS($0.95)
Net IncomeN/A
Net Margins-17.22%
Return on Equity-58.85%
Return on Assets-22.17%

Miscellaneous

Employees452
Outstanding Shares25,410,000

Imprivata (NYSE:IMPR) Frequently Asked Questions

What is Imprivata's stock symbol?

Imprivata trades on the New York Stock Exchange (NYSE) under the ticker symbol "IMPR."

How were Imprivata's earnings last quarter?

Imprivata Inc (NYSE:IMPR) issued its earnings results on Tuesday, February, 16th. The technology company reported ($0.09) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.01. The technology company had revenue of $34.20 million for the quarter, compared to analysts' expectations of $33.15 million. Imprivata had a negative net margin of 17.22% and a negative return on equity of 58.85%. The business's revenue was up 17.9% on a year-over-year basis. During the same quarter last year, the business earned ($0.04) earnings per share. View Imprivata's Earnings History.

Who are some of Imprivata's key competitors?

How do I buy Imprivata stock?

Shares of Imprivata can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Imprivata's stock price today?

One share of Imprivata stock can currently be purchased for approximately $19.26.

How big of a company is Imprivata?

Imprivata has a market capitalization of $492.60 million. Imprivata employs 452 workers across the globe.

How can I contact Imprivata?

Imprivata's mailing address is 10 Maguire Rd Bldg 1 Ste 125, LEXINGTON, MA 02421-3110, United States. The technology company can be reached via phone at +1-781-6742700.


MarketBeat Community Rating for Imprivata (IMPR)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  122 (Vote Outperform)
Underperform Votes:  71 (Vote Underperform)
Total Votes:  193
MarketBeat's community ratings are surveys of what our community members think about Imprivata and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Imprivata (NYSE:IMPR) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.202.172.29
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/A$16.00$16.33$16.20
Price Target Upside: N/A16.27% downside14.53% downside15.23% downside

Imprivata (NYSE:IMPR) Consensus Price Target History

Price Target History for Imprivata (NYSE:IMPR)

Imprivata (NYSE:IMPR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/2/2016Wells Fargo & CompanyDowngradeOutperform -> Market PerformN/AView Rating Details
7/14/2016Leerink SwannDowngradeOutperform -> Market PerformN/AView Rating Details
7/13/2016Stifel NicolausDowngradeBuy -> HoldN/AView Rating Details
7/13/2016Piper Jaffray CompaniesDowngradeOverweight -> NeutralN/AView Rating Details
5/31/2016OppenheimerReiterated RatingBuy$16.00N/AView Rating Details
5/4/2016J P Morgan Chase & CoReiterated RatingHold$17.00N/AView Rating Details
2/17/2016BarclaysLower Price TargetOverweight$15.00 -> $14.00N/AView Rating Details
(Data available from 12/13/2015 forward)

Earnings

Imprivata (NYSE:IMPR) Earnings History and Estimates Chart

Earnings by Quarter for Imprivata (NYSE:IMPR)

Imprivata (NYSE IMPR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/16/2016Q415($0.10)($0.09)$33.15 million$34.20 millionViewListenView Earnings Details
11/2/2015Q315($0.22)($0.27)$31.43 million$29.28 millionViewN/AView Earnings Details
7/29/2015Q215($0.21)($0.15)$29.26 million$30.00 millionViewListenView Earnings Details
5/4/2015Q115($0.31)($0.24)$24.55 million$25.60 millionViewN/AView Earnings Details
11/3/2014Q314($0.16)($0.16)$23.30 million$25.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Imprivata (NYSE:IMPR) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Imprivata (NYSE:IMPR)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Imprivata (NYSE IMPR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 40.20%
Institutional Ownership Percentage: 59.34%
Insider Trades by Quarter for Imprivata (NYSE:IMPR)
Institutional Ownership by Quarter for Imprivata (NYSE:IMPR)

Imprivata (NYSE IMPR) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/13/2016David TingCTOSell90,000$18.99$1,709,100.00View SEC Filing  
7/13/2016John A BlaeserDirectorSell7,500$19.01$142,575.00View SEC Filing  
7/12/2016Christopher A ShawSVPSell12,000$14.52$174,240.00View SEC Filing  
7/11/2016Christopher A ShawSVPSell2,300$14.50$33,350.00View SEC Filing  
5/27/2016Entrepreneurs Fund Ii L.P. GcMajor ShareholderSell46,586$13.49$628,445.14View SEC Filing  
5/5/2016Jeffrey KalowskiCFOSell10,000$12.98$129,800.00View SEC Filing  
4/29/2016Omar HussainCEOSell18,936$12.16$230,261.76View SEC Filing  
4/26/2016Omar HussainCEOSell18,564$12.38$229,822.32View SEC Filing  
4/25/2016Omar HussainCEOSell10,922$12.44$135,869.68View SEC Filing  
4/18/2016Thomas W BrigiottaSVPSell10,000$12.81$128,100.00View SEC Filing  
2/16/2016Thomas W. BrigiottaSVPSell10,000$11.24$112,400.00View SEC Filing  
1/15/2016Thomas W. BrigiottaSVPSell10,000$10.64$106,400.00View SEC Filing  
12/23/2015Omar HussainCEOSell30,000$10.70$321,000.00View SEC Filing  
12/1/2015Jeffrey KalowskiCFOSell5,000$11.54$57,700.00View SEC Filing  
11/17/2015Omar HussainCEOSell15,000$10.01$150,150.00View SEC Filing  
11/2/2015Jeffrey KalowskiCFOSell5,000$10.64$53,200.00View SEC Filing  
10/13/2015Jeffrey KalowskiCFOSell1,000$18.01$18,010.00View SEC Filing  
10/12/2015Jeffrey KalowskiCFOSell100$18.00$1,800.00View SEC Filing  
10/2/2015Thomas W. BrigiottaSVPSell5,000$16.68$83,400.00View SEC Filing  
10/1/2015David TingCTOSell8,000$17.32$138,560.00View SEC Filing  
10/1/2015Jeffrey KalowskiCFOSell5,000$17.27$86,350.00View SEC Filing  
9/15/2015Christopher A. ShawSVPSell4,000$19.99$79,960.00View SEC Filing  
9/15/2015Omar HussainCEOSell15,000$19.98$299,700.00View SEC Filing  
9/2/2015Thomas W. BrigiottaSVPSell10,000$19.23$192,300.00View SEC Filing  
9/1/2015Christopher A ShawSVPSell639$20.07$12,824.73View SEC Filing  
9/1/2015David TingCTOSell11,000$20.08$220,880.00View SEC Filing  
9/1/2015Jeffrey KalowskiCFOSell8,639$20.08$173,471.12View SEC Filing  
8/17/2015Omar HussainCEOSell15,000$19.64$294,600.00View SEC Filing  
8/17/2015Thomas W. BrigiottaSVPSell20,000$19.98$399,600.00View SEC Filing  
7/22/2015David TingCTOSell1,229$17.01$20,905.29View SEC Filing  
7/17/2015Christopher A ShawSVPSell2,000$16.01$32,020.00View SEC Filing  
7/15/2015Omar HussainCEOSell10,000$15.78$157,800.00View SEC Filing  
7/2/2015Jeffrey KalowskiCFOSell7,000$15.54$108,780.00View SEC Filing  
7/2/2015Thomas W BrigiottaSVPSell5,000$15.49$77,450.00View SEC Filing  
6/24/2015Christopher A ShawSVPSell2,000$16.10$32,200.00View SEC Filing  
6/18/2015David TingCTOSell3,112$16.30$50,725.60View SEC Filing  
6/16/2015Omar HussainCEOSell10,000$15.00$150,000.00View SEC Filing  
6/2/2015Jeffrey KalowskiCFOSell7,000$15.47$108,290.00View SEC Filing  
6/2/2015Thomas W BrigiottaSVPSell10,000$15.47$154,700.00View SEC Filing  
5/22/2015David TingCTOSell4,383$16.01$70,171.83View SEC Filing  
5/18/2015Omar HussainCEOSell10,000$15.03$150,300.00View SEC Filing  
5/11/2015Christopher A ShawSVPSell2,562$15.05$38,558.10View SEC Filing  
5/8/2015Thomas W BrigiottaSVPSell1,276$15.09$19,254.84View SEC Filing  
5/5/2015Omar HussainCEOSell1,003$15.00$15,045.00View SEC Filing  
5/5/2015Thomas W BrigiottaSVPSell1,155$15.00$17,325.00View SEC Filing  
4/30/2015Christopher A ShawSVPSell1,340$15.01$20,113.40View SEC Filing  
4/30/2015Omar HussainCEOSell2,233$15.01$33,517.33View SEC Filing  
4/23/2015Christopher A ShawSVPSell4,690$15.02$70,443.80View SEC Filing  
4/23/2015David TingCTOSell3,126$15.02$46,952.52View SEC Filing  
4/23/2015Omar HussainCEOSell7,816$15.02$117,396.32View SEC Filing  
4/7/2015Jeffrey KalowskiCFOSell3,701$13.17$48,742.17View SEC Filing  
4/6/2015Jeffrey KalowskiCFOSell6,299$13.76$86,674.24View SEC Filing  
3/31/2015Thomas W BrigiottaSVPSell10,000$13.91$139,100.00View SEC Filing  
6/30/2014David J OrfaoDirectorBuy10,000$13.95$139,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Imprivata (NYSE IMPR) News Headlines

Source:
DateHeadline
Comparing Imprivata (IMPR) and Workiva (WK)Comparing Imprivata (IMPR) and Workiva (WK)
www.americanbankingnews.com - October 28 at 11:18 PM
Five things you need to know today, and your mail-order friend is readyFive things you need to know today, and your mail-order friend is ready
www.bizjournals.com - October 26 at 11:43 PM
Critical Contrast: Imprivata (IMPR) vs. Its RivalsCritical Contrast: Imprivata (IMPR) vs. Its Rivals
www.americanbankingnews.com - October 6 at 8:30 PM
Financial Analysis: Imprivata (IMPR) & Bridgeline Digital (BLIN)Financial Analysis: Imprivata (IMPR) & Bridgeline Digital (BLIN)
www.americanbankingnews.com - October 4 at 2:10 AM
Imprivata and Just Associates Partner to Ensure Accurate Patient Identification and Data Integrity at Every Point of ... - Business Wire (press release)Imprivata and Just Associates Partner to Ensure Accurate Patient Identification and Data Integrity at Every Point of ... - Business Wire (press release)
www.businesswire.com - September 28 at 12:02 PM
Imprivata and Just Associates Partner to Ensure Accurate Patient Identification and Data Integrity at Every Point of CareImprivata and Just Associates Partner to Ensure Accurate Patient Identification and Data Integrity at Every Point of Care
www.businesswire.com - September 27 at 5:03 PM
Imprivata (IMPR) vs. Its Rivals Critical AnalysisImprivata (IMPR) vs. Its Rivals Critical Analysis
www.americanbankingnews.com - September 25 at 10:28 AM
Critical Contrast: Imprivata (IMPR) vs. Q2 Holdings (QTWO)Critical Contrast: Imprivata (IMPR) vs. Q2 Holdings (QTWO)
www.americanbankingnews.com - August 31 at 4:24 PM
Imprivata Joins CommonWell Health Alliance with the Goal to Deploy Positive Patient Identification Interoperability CapabilitiesImprivata Joins CommonWell Health Alliance with the Goal to Deploy Positive Patient Identification Interoperability Capabilities
www.businesswire.com - August 18 at 7:41 PM
Garden doctor concept wins Apps for Ag Hackathon'Garden doctor' concept wins Apps for Ag Hackathon
www.bizjournals.com - August 1 at 8:33 PM
Top cybersecurity execs, local investors back Edgewise NetworksTop cybersecurity execs, local investors back Edgewise Networks
www.bizjournals.com - July 13 at 3:09 AM
IGEL Names Brad Tompkins Vice President of Sales for North AmericaIGEL Names Brad Tompkins Vice President of Sales for North America
www.businesswire.com - May 2 at 4:20 PM
CFO Moves: Anixter International, Rapid7, HSNCFO Moves: Anixter International, Rapid7, HSN
blogs.wsj.com - November 29 at 4:34 PM
CFO Moves: Anixter International, Rapid7, HSNCFO Moves: Anixter International, Rapid7, HSN
blogs.wsj.com - November 29 at 4:34 PM
BRIEF-Unilever says to acquires Seventh Generation IncBRIEF-Unilever says to acquires Seventh Generation Inc
www.reuters.com - September 19 at 5:40 PM
Days after buyout closes, Imprivata announces new CEODays after buyout closes, Imprivata announces new CEO
www.bizjournals.com - September 19 at 5:40 PM
IMPRIVATA INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersIMPRIVATA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - September 14 at 5:44 PM
Thoma Bravo Raises $7.6 Billion for Software, Technology BuyoutsThoma Bravo Raises $7.6 Billion for Software, Technology Buyouts
www.bloomberg.com - September 12 at 5:29 PM
NIRI Boston Announces its Board of Directors for the 2016-2017 Programming YearNIRI Boston Announces its Board of Directors for the 2016-2017 Programming Year
www.businesswire.com - September 8 at 5:30 PM

SEC Filings

Imprivata (NYSE:IMPR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Imprivata (NYSE:IMPR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Imprivata (NYSE IMPR) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.